global sales
Leqembi’s Global Sales Reach $67 Million, Yet US Adoption Faces Hurdles
Leqembi, Biogen, Eisai, Alzheimer’s disease, global sales, US adoption challenges
Actionable Insights Powered by AI
Leqembi, Biogen, Eisai, Alzheimer’s disease, global sales, US adoption challenges